VGAT Vesicular GABA Transporter Neurons

Vesicular GABA Transporter (VGAT) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">VGAT Vesicular GABA Transporter Neurons</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SLC32A1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>20q11.23</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>525 amino acids</td>
</tr>
<tr>
<td class="label">Topology</td>
<td>10 transmembrane domains</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Major facilitator superfamily (MFS)</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Affinity (Km)</td>
</tr>
<tr>
<td class="label">GABA</td>
<td>0.2-0.5 mM</td>
</tr>
<tr>
<td class="label">Glycine</td>
<td>0.5-1.0 mM</td>
</tr>
<tr>
<td class="label">Beta-alanine</td>
<td>2-5 mM</td>
</tr>
<tr>
<td class="label">Taurine</td>
<td>5-10 mM</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Parvalbumin (PV+)</td>
<td>Cortex, hippocampus</td>
</tr>
<tr>
<td class="label">Somatostatin (SST+)</td>
<td>Cortex, hippocampus</td>
</tr>
<tr>
<td class="label">Calretinin (CR+)</td>
<td>Cortex</td>
</tr>
<tr>
<td class="label">VIP+</td>
<td>Cortex</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Benzodiazepines</td>
<td>GABA_A positive modulators</td>

...

Vesicular GABA Transporter (VGAT) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">VGAT Vesicular GABA Transporter Neurons</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SLC32A1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>20q11.23</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>525 amino acids</td>
</tr>
<tr>
<td class="label">Topology</td>
<td>10 transmembrane domains</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Major facilitator superfamily (MFS)</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Affinity (Km)</td>
</tr>
<tr>
<td class="label">GABA</td>
<td>0.2-0.5 mM</td>
</tr>
<tr>
<td class="label">Glycine</td>
<td>0.5-1.0 mM</td>
</tr>
<tr>
<td class="label">Beta-alanine</td>
<td>2-5 mM</td>
</tr>
<tr>
<td class="label">Taurine</td>
<td>5-10 mM</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Location</td>
</tr>
<tr>
<td class="label">Parvalbumin (PV+)</td>
<td>Cortex, hippocampus</td>
</tr>
<tr>
<td class="label">Somatostatin (SST+)</td>
<td>Cortex, hippocampus</td>
</tr>
<tr>
<td class="label">Calretinin (CR+)</td>
<td>Cortex</td>
</tr>
<tr>
<td class="label">VIP+</td>
<td>Cortex</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Benzodiazepines</td>
<td>GABA_A positive modulators</td>
</tr>
<tr>
<td class="label">Barbiturates</td>
<td>GABA_A agonists</td>
</tr>
<tr>
<td class="label">Tiagabine</td>
<td>GABA transporter blocker</td>
</tr>
<tr>
<td class="label">Vigabatrin</td>
<td>GABA transaminase inhibitor</td>
</tr>
<tr>
<td class="label">Baclofen</td>
<td>GABA_B agonists</td>
</tr>
</table>

Overview

Vgat Vesicular Gaba Transporter [Neurons](/entities/neurons) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

VGAT (Vesicular GABA Transporter), also known as SLC32A1, is responsible for transporting GABA and glycine into synaptic vesicles, enabling inhibitory neurotransmission throughout the central nervous system. VGAT-expressing neurons constitute the primary inhibitory network, regulating neural excitability, network oscillations, and information processing. Mutations in VGAT have been implicated in epilepsy, hyperekplexia, and various neurodegenerative disorders including [Alzheimer's disease](/diseases/alzheimers-disease) (AD), [Parkinson's disease](/diseases/parkinsons-disease) (PD), and amyotrophic lateral sclerosis (ALS) [1](https://pubmed.ncbi.nlm.nih.gov/16643546/). [@palop2011]

Molecular Biology

VGAT Gene and Protein

Transport Mechanism

VGAT operates as a H+/GABA antiporter, using the proton gradient established by V-ATPase to drive GABA and glycine uptake into synaptic vesicles. The transport cycle involves:

Vesicle acidification: V-ATPase pumps H+ into the vesicle

Substrate binding: GABA or glycine binds to VGAT

Exchange: H+ exits while substrate enters

Vesicle fusion: Fuses with presynaptic membrane for release

Substrate Specificity

Neuroanatomy

Distribution

VGAT-expressing neurons are广泛分布 throughout the CNS:

• Cerebral [cortex](/brain-regions/cortex): 20-30% of cortical neurons are GABAergic
• [Hippocampus](/brain-regions/hippocampus): Interneurons targeting pyramidal cells
• Basal ganglia: GPe, GPi, striatal interneurons
• Cerebellum: Molecular layer interneurons, Golgi cells
• Brainstem: Reticular formation, raphe nuclei
• Spinal cord: Lamina I-II inhibitory interneurons

Neuronal Subtypes

Electrophysiology

Properties of VGAT Neurons

Resting membrane potential: More negative (-70 to -80 mV)

Input resistance: Higher than excitatory neurons

Firing patterns: Regular spiking, fast-spiking, burst

Synaptic currents: IPSPs, inhibitory postsynaptic currents

Inhibitory Signaling

GABAergic signaling through VGAT neurons produces:

• Phasic inhibition: Fast IPSPs (1-5 ms rise, 10-50 ms decay)
• Tonic inhibition: Persistent current via extrasynaptic GABA_A receptors
• Network oscillations: Gamma (30-80 Hz), theta (4-8 Hz) rhythms

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

VGAT neurons are affected in AD through multiple mechanisms:

• Inhibitory neuron loss: Reduced PV+ and SST+ interneurons in AD cortex [2](https://pubmed.ncbi.nlm.nih.gov/24418190/)
• GABAergic dysfunction: Impaired GABA synthesis and release
• Network disruption: Loss of gamma oscillations correlates with cognitive decline
• Excitotoxicity: Secondary loss due to excitatory neuron dysfunction
• Amyloid effects: [Aβ](/proteins/amyloid-beta) directly reduces VGAT expression

Parkinson's Disease (PD)

• Striatal interneurons: Reduced inhibition contributes to motor symptoms
• Beta oscillations: Enhanced beta-frequency activity in PD
• Subthalamic nucleus: Increased GABAergic output from GPe
• Deep brain stimulation: Modulates VGAT neuron activity
• Dyskinesias: Altered GABAergic signaling

Amyotrophic Lateral sclerosis (ALS)

• Inhibitory dysfunction: Reduced GABAergic transmission in motor cortex
• Spinal cord: Loss of glycinergic and GABAergic interneurons
• Hyperexcitability: Reduced inhibition contributes to motor neuron degeneration
• Therapeutic target: GABA_A agonists show neuroprotective effects

Epilepsy

• VGAT mutations: Cause familial epilepsy and infantile seizures [3](https://pubmed.ncbi.nlm.nih.gov/20600047/)
• Inhibitory failure: Reduced inhibition precipitates seizures
• Therapeutic targets: GABAergic drugs (benzodiazepines, barbiturates)

Huntington's Disease (HD)

• Early loss: GABAergic interneurons are affected early
• Motor cortex: Reduced PV+ neuron density
• Network dysfunction: Contributes to chorea and cognitive deficits
• Therapeutic approaches: GABA_B agonists show promise

Clinical Significance

Therapeutic Targeting

Genetic Disorders

VGAT mutations (SLC32A1): Early infantile epilepsy, developmental delay

PCHD19: Associated with epilepsy and developmental disorders

ALDH5A1: Succinic semialdehyde dehydrogenase deficiency

Research Directions

Current research focuses on:

• Single-cell transcriptomics of VGAT neuronal subtypes
• Optogenetic dissection of inhibitory circuits
• VGAT-targeted gene therapy for epilepsy
• Understanding inhibitory dysfunction in neurodegeneration

See Also

• [/cell-types](/cell-types) - All cell types
• [Neurodegeneration](/diseases/neurodegeneration) - Neurodegeneration
• [Neuroinflammation](/mechanisms/neuroinflammation) - Neuroinflammation
• [/mechanisms](/mechanisms) - All mechanisms

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
• [NeuroMorph](https://neuromorph.org/) - Neuronal morphology database

Overview

Vgat Vesicular Gaba Transporter Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Vgat Vesicular Gaba Transporter Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving VGAT Vesicular GABA Transporter Neurons discovered through SciDEX knowledge graph analysis: